| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis
|
Siddiqi, Ahmed Kamal
|
|
|
|
2 |
p. 273-284
|
artikel
|
| 2 |
Acetylsalicylic Acid Reduces Niacin Extended-Release-Induced Flushing in Patients with Dyslipidemia
|
Thakkar, Roopal B.
|
|
2009
|
|
2 |
p. 69-79
|
artikel
|
| 3 |
Acute Effects of Tobacco Chewing on the Systemic, Pulmonary and Coronary Circulation
|
Ramakrishnan, Sivasubramanian
|
|
2011
|
|
2 |
p. 109-114
|
artikel
|
| 4 |
Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine
|
Pereira-Barretto, Antonio Carlos
|
|
2016
|
|
2 |
p. 93-101
|
artikel
|
| 5 |
Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation
|
Hernandez, Inmaculada
|
|
|
|
2 |
p. 199-207
|
artikel
|
| 6 |
Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study
|
Spreafico, Marta
|
|
|
|
2 |
p. 179-190
|
artikel
|
| 7 |
Adjuvant Antiarrhythmic Therapy in Patients with Implantable Cardioverter Defibrillators
|
Bunch, T. Jared
|
|
2013
|
|
2 |
p. 89-100
|
artikel
|
| 8 |
Alirocumab: A Review in Hypercholesterolemia
|
Greig, Sarah L.
|
|
2016
|
|
2 |
p. 141-152
|
artikel
|
| 9 |
Antianginal Effects of Trimetazidine and Left Ventricular Function Improvement in Patients with Stable Angina Pectoris
|
Shlyakhto, Evgeniy V.
|
|
2002
|
|
2 |
p. 119-124
|
artikel
|
| 10 |
Antihypertensive Drugs
|
Ram, C. Venkata S.
|
|
2002
|
|
2 |
p. 77-89
|
artikel
|
| 11 |
Antihypertensive Drugs, Hypotension, and Ischemic Colitis
|
Blin, Patrick
|
|
2015
|
|
2 |
p. 77-79
|
artikel
|
| 12 |
Antihypertensive Efficacy of Triple Combination Perindopril/Indapamide Plus Amlodipine in High-Risk Hypertensives: Results of the PIANIST Study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients)
|
Tóth, Kálmán
|
|
2014
|
|
2 |
p. 137-145
|
artikel
|
| 13 |
Are All Statins the Same?
|
Silva, Pedro Marques da
|
|
2011
|
|
2 |
p. 93-107
|
artikel
|
| 14 |
Aspirin and Platelet Adenosine Diphosphate Receptor Antagonists in Acute Coronary Syndromes and Percutaneous Coronary Intervention
|
Depta, Jeremiah P.
|
|
2008
|
|
2 |
p. 91-112
|
artikel
|
| 15 |
Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis
|
Bellos, Ioannis
|
|
|
|
2 |
p. 241-253
|
artikel
|
| 16 |
Assessment of Non-vitamin K Oral Anticoagulants Use in a Tertiary Care Center in the USA: A Chart Review of 909 Patients
|
Sheikh-Taha, Marwan
|
|
2018
|
|
2 |
p. 195-201
|
artikel
|
| 17 |
Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis
|
Hou, Qingtao
|
|
|
|
2 |
p. 183-193
|
artikel
|
| 18 |
A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach?
|
Brotons, Carlos
|
|
2014
|
|
2 |
p. 113-133
|
artikel
|
| 19 |
Author Correction to: Comparative Efficacy of Drugs for Preventing Acute Kidney Injury after Cardiac Surgery: A Network Meta-Analysis
|
Chen, Xi
|
|
2018
|
|
2 |
p. 153
|
artikel
|
| 20 |
Author Correction to: Recent Perioperative Pharmacological Prevention of Acute Kidney Injury after Cardiac Surgery: A Narrative Review
|
Li, Shurong
|
|
2018
|
|
2 |
p. 155
|
artikel
|
| 21 |
Author’s Reply to Kow et al.: “Comparison of Clinical Outcomes between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study”
|
Fang, Hsiu-Yu
|
|
|
|
2 |
p. 327-328
|
artikel
|
| 22 |
Authors’ Reply to Rana et al. “Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials”
|
Misra, Usha K.
|
|
2019
|
|
2 |
p. 223-224
|
artikel
|
| 23 |
Beta-Blockers and Ivabradine in Chronic Heart Failure: From Clinical Trials to Clinical Practice
|
Franco, Antonino Di
|
|
2013
|
|
2 |
p. 101-110
|
artikel
|
| 24 |
Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors)
|
Liakos, Charalampos I.
|
|
|
|
2 |
p. 123-137
|
artikel
|
| 25 |
Calcium Intake and Risk of Cardiovascular Disease
|
Wang, Lu
|
|
2012
|
|
2 |
p. 105-116
|
artikel
|
| 26 |
Cardiovascular Pharmacotherapy in Patients with Marfan Syndrome
|
Yetman, Anji T.
|
|
2007
|
|
2 |
p. 117-126
|
artikel
|
| 27 |
Cardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials
|
Elgendy, Islam Y.
|
|
2016
|
|
2 |
p. 143-155
|
artikel
|
| 28 |
Cilostazol in Acute Myocardial Infarction: New Tricks for an Old Drug?
|
Adamson, Philip
|
|
2014
|
|
2 |
p. 129-130
|
artikel
|
| 29 |
Clevidipine
|
Deeks, Emma D.
|
|
2009
|
|
2 |
p. 117-134
|
artikel
|
| 30 |
Clinical Pharmacology and Cardiovascular Safety of Naproxen
|
Angiolillo, Dominick J.
|
|
2016
|
|
2 |
p. 97-107
|
artikel
|
| 31 |
Clinical Potential of Nonhemoglobin Oxygen Therapeutics in Cardiac and General Surgery
|
Wahr, Joyce A.
|
|
2002
|
|
2 |
p. 69-75
|
artikel
|
| 32 |
Colesevelam
|
Ansell, Benjamin J.
|
|
2001
|
|
2 |
p. 147-148
|
artikel
|
| 33 |
Colesevelam
|
Melian, Ezequiel Balmori
|
|
2001
|
|
2 |
p. 141-146
|
artikel
|
| 34 |
Colesevelam
|
Shepherd, James
|
|
2001
|
|
2 |
p. 147
|
artikel
|
| 35 |
Combination of Amlodipine plus Angiotensin Receptor Blocker or Diuretics in High-Risk Hypertensive Patients
|
Ma, Liyuan
|
|
2012
|
|
2 |
p. 137-142
|
artikel
|
| 36 |
Comment on: “Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study”
|
Kow, Chia Siang
|
|
|
|
2 |
p. 325-326
|
artikel
|
| 37 |
Comment on: “Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials”
|
Rana, Prashant B.
|
|
2019
|
|
2 |
p. 219-221
|
artikel
|
| 38 |
Comment on: “Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials”
|
Rana, Prashant B.
|
|
|
|
2 |
p. 219-221
|
artikel
|
| 39 |
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis
|
Elshafei, Mohamed Nabil
|
|
|
|
2 |
p. 255-271
|
artikel
|
| 40 |
Comparing the Impact of Prescription Omega-3 Fatty Acid Products on Low-Density Lipoprotein Cholesterol
|
Sharp, Randall P.
|
|
2017
|
|
2 |
p. 83-92
|
artikel
|
| 41 |
Comparison of Efficacy of Low- (80 mg/day) and High- (160–320 mg/day) Dose Valsartan in the Prevention of In-Stent Restenosis after Implantation of Bare-Metal Stents in Type B2/C Coronary Artery Lesions
|
Peters, Stefan
|
|
2008
|
|
2 |
p. 83-87
|
artikel
|
| 42 |
Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation and Concomitant Liver Cirrhosis: A Systematic Review and Meta-Analysis
|
Lee, Zhi-Yan
|
|
|
|
2 |
p. 157-165
|
artikel
|
| 43 |
Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice
|
Gonzalez-Quesada, Carlos J.
|
|
2014
|
|
2 |
p. 111-127
|
artikel
|
| 44 |
Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study
|
Millán Núñez-Cortés, Jesús
|
|
2016
|
|
2 |
p. 135-142
|
artikel
|
| 45 |
Continuous Ultrafiltration in Acute Decompensated Heart Failure: Current Issues and Future Directions
|
Marenzi, Giancarlo
|
|
2015
|
|
2 |
p. 103-112
|
artikel
|
| 46 |
Coronary Artery Disease in Patients with HIV Infection
|
Patel, Amish A.
|
|
2015
|
|
2 |
p. 81-87
|
artikel
|
| 47 |
Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock
|
Senatore, Fortunato
|
|
2019
|
|
2 |
p. 227
|
artikel
|
| 48 |
Correction to: Plasma Vitamin K1 Levels in Italian Patients Receiving Oral Anticoagulant Therapy for Mechanical Heart Prosthesis: A Case–Control Study
|
Cafolla, Arturo
|
|
2019
|
|
2 |
p. 225
|
artikel
|
| 49 |
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial
|
Claassens, Daniel M. F.
|
|
|
|
2 |
p. 195-206
|
artikel
|
| 50 |
Cost Effectiveness of Adding Dapagliflozin to Standard Care in Heart Failure Patients with Reduced Ejection Fraction: A Systematic Review
|
Rezapour, Aziz
|
|
|
|
2 |
p. 127-144
|
artikel
|
| 51 |
Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective
|
Athanasakis, Kostas
|
|
2016
|
|
2 |
p. 123-133
|
artikel
|
| 52 |
Current Evidence for Pharmacologic Reversal Using Direct Oral Anticoagulants: What’s New?
|
Zhao, Shujuan
|
|
|
|
2 |
p. 117-123
|
artikel
|
| 53 |
Current Management of Symptomatic Atrial Fibrillation
|
Haghi, Dariusch
|
|
2001
|
|
2 |
p. 127-139
|
artikel
|
| 54 |
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials
|
van den Broek, Wout W. A.
|
|
|
|
2 |
p. 165-172
|
artikel
|
| 55 |
Defining the Role of PCSK9 Inhibitors in the Treatment of Hyperlipidemia
|
Whayne, Thomas F.
|
|
2015
|
|
2 |
p. 83-92
|
artikel
|
| 56 |
Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation Treatment: Rural and Urban Trends in Medicare Beneficiaries
|
Norby, Faye L.
|
|
|
|
2 |
p. 207-217
|
artikel
|
| 57 |
Disparity in the Application of Guideline-Based Medical Therapy after Percutaneous Coronary Intervention: Analysis from the Japanese Prospective Multicenter Registry
|
Endo, Ayaka
|
|
2013
|
|
2 |
p. 103-112
|
artikel
|
| 58 |
Does Coenzyme Q10 Supplementation Mitigate Statin-Associated Muscle Symptoms? Pharmacological and Methodological Considerations
|
Taylor, Beth A.
|
|
2017
|
|
2 |
p. 75-82
|
artikel
|
| 59 |
Drug Treatment of Obesity in Cardiovascular Disease
|
Charakida, Marietta
|
|
2012
|
|
2 |
p. 93-104
|
artikel
|
| 60 |
Drug Treatment of Patients with Decompensated Heart Failure
|
Mills, Roger M.
|
|
2001
|
|
2 |
p. 119-125
|
artikel
|
| 61 |
Edoxaban Tosylate
|
|
|
2011
|
|
2 |
p. 129-135
|
artikel
|
| 62 |
Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects
|
Wang, Xiaoli
|
|
2013
|
|
2 |
p. 147-154
|
artikel
|
| 63 |
Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
|
Vakkalagadda, Blisse
|
|
2016
|
|
2 |
p. 119-127
|
artikel
|
| 64 |
Effect of Time to Titration to Maximum Dose of Statins on Cardiovascular Outcomes
|
Friend, Amy S.
|
|
2009
|
|
2 |
p. 103-107
|
artikel
|
| 65 |
Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials
|
Shi, Liye
|
|
|
|
2 |
p. 191-198
|
artikel
|
| 66 |
Effects of the Sodium-Glucose Cotransporter Inhibitors on Cardiovascular Death and All-Cause Mortality: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Clinical Trials
|
Eraikhuemen, Nathaniel
|
|
|
|
2 |
p. 113-126
|
artikel
|
| 67 |
Effects on Coronary Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol with Statins
|
Ferrières, Jean
|
|
2009
|
|
2 |
p. 109-115
|
artikel
|
| 68 |
Efficacy and Safety of Coadministration of Fenofibrate and Ezetimibe Compared with Each as Monotherapy in Patients with Type IIb Dyslipidemia and Features of the Metabolic Syndrome
|
Ansquer, Jean-Claude
|
|
2009
|
|
2 |
p. 91-101
|
artikel
|
| 69 |
Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus
|
Jones, Peter H.
|
|
2010
|
|
2 |
p. 73-84
|
artikel
|
| 70 |
Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
|
Kuang, Hong-yu
|
|
|
|
2 |
p. 181-191
|
artikel
|
| 71 |
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
|
Sohn, Il Suk
|
|
2015
|
|
2 |
p. 129-138
|
artikel
|
| 72 |
Efficacy of Intravenous Iron in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: A Systematic Review and Meta-Analysis of Randomized Control Trials
|
Sephien, Andrew
|
|
|
|
2 |
p. 285-302
|
artikel
|
| 73 |
Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea
|
Kim, Eui-Soon
|
|
|
|
2 |
p. 313-324
|
artikel
|
| 74 |
Erratum to: ACE Inhibition Modulates Endothelial Apoptosis and Renewal via Endothelial Progenitor Cells in Patients with Acute Coronary Syndromes
|
Cangiano, Elisa
|
|
2012
|
|
2 |
p. 126
|
artikel
|
| 75 |
Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
|
Sohn, Il Suk
|
|
2016
|
|
2 |
p. 139
|
artikel
|
| 76 |
Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia
|
Willson, Megan N.
|
|
2010
|
|
2 |
p. 105-108
|
artikel
|
| 77 |
Evaluating the Safety and Tolerability of Sacubitril/Valsartan for HFrEF Managed Within a Pharmacist Clinic
|
Pogge, Elizabeth K.
|
|
2018
|
|
2 |
p. 143-151
|
artikel
|
| 78 |
Evidence-Based Medical Therapy of Patients with Acute Coronary Syndromes
|
Ramanath, Vijay S.
|
|
2007
|
|
2 |
p. 95-116
|
artikel
|
| 79 |
Ex Ante Economic Evaluation of Arg389 Genetically Targeted Treatment with Bucindolol versus Empirical Treatment with Carvedilol in NYHA III/IV Heart Failure
|
Alkhatib, Nimer
|
|
|
|
2 |
p. 205-217
|
artikel
|
| 80 |
Exploring Medication Adherence with P2Y12 Inhibitors Using Conditional and Unconditional Quantile Regression Approaches
|
Suh, Kangho
|
|
|
|
2 |
p. 193-204
|
artikel
|
| 81 |
Extent of Control of Cardiovascular Risk Factors and Adherence to Recommended Therapies in US Multiethnic Adults with Coronary Heart Disease
|
Vulic, Dusko
|
|
2010
|
|
2 |
p. 109-114
|
artikel
|
| 82 |
Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 Study
|
Montalescot, Gilles
|
|
|
|
2 |
p. 207-217
|
artikel
|
| 83 |
Fondaparinux Sodium
|
Blick, Stephanie K. A.
|
|
2008
|
|
2 |
p. 113-125
|
artikel
|
| 84 |
From the World Literature
|
|
|
2001
|
|
2 |
p. 149-158
|
artikel
|
| 85 |
Heterogeneity of Efficacy and Safety of Antiplatelet Therapy in Cardiovascular and Cerebrovascular Disease
|
Gebel, James M.
|
|
2010
|
|
2 |
p. 115-124
|
artikel
|
| 86 |
How Might Bromodomain and Extra-Terminal (BET) Inhibitors Operate in Cardiovascular Disease?
|
Schooling, C. Mary
|
|
2019
|
|
2 |
p. 107-111
|
artikel
|
| 87 |
Impact of Perioperative Levosimendan Administration on Risk of Bleeding After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials
|
Yan, Sen-bo
|
|
|
|
2 |
p. 149-160
|
artikel
|
| 88 |
Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study
|
Kim, Yong Hoon
|
|
2017
|
|
2 |
p. 117-127
|
artikel
|
| 89 |
Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol
|
Demerouti, Eftychia
|
|
2019
|
|
2 |
p. 99-105
|
artikel
|
| 90 |
Incidence of Ischemic Colitis in Treated, Commercially Insured Hypertensive Adults: A Cohort Study of US Health Claims Data
|
Hines, Dionne Mayhew
|
|
2014
|
|
2 |
p. 135-149
|
artikel
|
| 91 |
Inclisiran: A Review in Hypercholesterolemia
|
Frampton, James E.
|
|
|
|
2 |
p. 219-230
|
artikel
|
| 92 |
Increased Risk of Heart Failure in Elderly Patients Treated with Beta-Blockers After AV Node Ablation
|
Bertomeu-Gonzalez, Vicente
|
|
|
|
2 |
p. 157-164
|
artikel
|
| 93 |
Integrating Real-World Evidence in Economic Evaluation of Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation in a Developing Country
|
Syeed, M. Sakil
|
|
|
|
2 |
p. 173-183
|
artikel
|
| 94 |
Irbesartan/Amlodipine: A Review of its Use in Adult Patients with Essential Hypertension Not Adequately Controlled with Monotherapy
|
Garnock-Jones, Karly P.
|
|
2013
|
|
2 |
p. 141-150
|
artikel
|
| 95 |
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
|
Rossi, Maddalena
|
|
|
|
2 |
p. 141-155
|
artikel
|
| 96 |
Long-Term Benefit of Statin Therapy Initiated during Hospitalization for an Acute Coronary Syndrome
|
Bavry, Anthony A.
|
|
2007
|
|
2 |
p. 135-141
|
artikel
|
| 97 |
Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial
|
De Haro, Joaquin
|
|
2018
|
|
2 |
p. 203-209
|
artikel
|
| 98 |
Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia
|
Karas, Richard H.
|
|
2008
|
|
2 |
p. 69-81
|
artikel
|
| 99 |
Low-Dose Aspirin Therapy for Cardiovascular Prevention
|
Herlitz, Johan
|
|
2010
|
|
2 |
p. 125-141
|
artikel
|
| 100 |
Management of Hypertension in the Asia-Pacific Region: A Structured Review
|
Rahman, Abdul R. A.
|
|
|
|
2 |
p. 141-170
|
artikel
|
| 101 |
Management of Protease Inhibitor-Associated Hyperlipidemia
|
Penzak, Scott R.
|
|
2002
|
|
2 |
p. 91-106
|
artikel
|
| 102 |
Management of Pump Thrombosis in Patients with Left Ventricular Assist Devices
|
Stulak, John M.
|
|
2015
|
|
2 |
p. 89-94
|
artikel
|
| 103 |
Mechanisms Underlying Ventricular Arrhythmias in Idiopathic Dilated Cardiomyopathy
|
Merino, Jose L.
|
|
2001
|
|
2 |
p. 105-118
|
artikel
|
| 104 |
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
|
Casula, Matteo
|
|
|
|
2 |
p. 231-240
|
artikel
|
| 105 |
Meta-Analysis of Oral Anticoagulants with Dual versus Single Antiplatelet Therapy in Patients after Percutaneous Coronary Intervention
|
Briasoulis, Alexandros
|
|
2015
|
|
2 |
p. 103-110
|
artikel
|
| 106 |
Micronized Fenofibrate
|
Kiortsis, Dimitrios N.
|
|
2002
|
|
2 |
p. 133-134
|
artikel
|
| 107 |
Micronized Fenofibrate
|
Després, Jean-Pierre
|
|
2002
|
|
2 |
p. 133
|
artikel
|
| 108 |
Micronized Fenofibrate
|
Doughty, Robert N.
|
|
2002
|
|
2 |
p. 133
|
artikel
|
| 109 |
Micronized Fenofibrate in Dyslipidemia
|
Sharpe, Miriam
|
|
2002
|
|
2 |
p. 125-132
|
artikel
|
| 110 |
Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?
|
Rubboli, Andrea
|
|
|
|
2 |
p. 113-115
|
artikel
|
| 111 |
Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine
|
Lapostolle, Frédéric
|
|
2018
|
|
2 |
p. 173-183
|
artikel
|
| 112 |
Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis
|
Seleme, Vinícius Bocchino
|
|
|
|
2 |
p. 165-180
|
artikel
|
| 113 |
New Perspectives on the Role and Therapeutic Potential of Melatonin in Cardiovascular Diseases
|
Gu, Pengchen
|
|
|
|
2 |
p. 171-195
|
artikel
|
| 114 |
New Strategies to Prevent Restenosis
|
Kester, Mark
|
|
2001
|
|
2 |
p. 77-83
|
artikel
|
| 115 |
Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review
|
Fu, Yonghui
|
|
|
|
2 |
p. 139-147
|
artikel
|
| 116 |
Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant Drugs
|
Proietti, Marco
|
|
|
|
2 |
p. 125-137
|
artikel
|
| 117 |
One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database
|
Effron, Mark B.
|
|
2017
|
|
2 |
p. 129-141
|
artikel
|
| 118 |
One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia
|
Ferdinand, Keith C.
|
|
2012
|
|
2 |
p. 117-125
|
artikel
|
| 119 |
Opinion and Evidence in Cardiovascular Therapeutics
|
|
|
2002
|
|
2 |
p. 135-144
|
artikel
|
| 120 |
Optimal Medical Management in Patients with Renovascular Hypertension
|
Balafa, Olga
|
|
2013
|
|
2 |
p. 71-78
|
artikel
|
| 121 |
Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality
|
Fox, Ashley N.
|
|
2018
|
|
2 |
p. 185-193
|
artikel
|
| 122 |
Optimal Medical Therapy Prescription in Patients with Acute Coronary Syndrome in the Netherlands: A Multicenter Pilot Registry
|
Hoedemaker, Niels P. G.
|
|
|
|
2 |
p. 219-229
|
artikel
|
| 123 |
Ozone: A New Therapeutic Agent in Vascular Diseases
|
Bocci, Velio
|
|
2011
|
|
2 |
p. 73-82
|
artikel
|
| 124 |
Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 Inhibitors
|
Rane, Pallavi B.
|
|
2017
|
|
2 |
p. 103-108
|
artikel
|
| 125 |
Patients With Atherosclerotic Vascular Disease
|
Spence, David
|
|
2001
|
|
2 |
p. 85-89
|
artikel
|
| 126 |
Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use
|
Syed, Yahiya Y.
|
|
|
|
2 |
p. 219-230
|
artikel
|
| 127 |
Pharmacogenetics in Cardiovascular Disorders: An Update on the Principal Drugs
|
Predazzi, Irene M.
|
|
2013
|
|
2 |
p. 79-85
|
artikel
|
| 128 |
Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole
|
Offman, Elliot
|
|
2013
|
|
2 |
p. 113-120
|
artikel
|
| 129 |
Pharmacologic Management of Arrhythmias in Patients with Congenital Heart Disease
|
Batra, Anjan S.
|
|
2001
|
|
2 |
p. 91-103
|
artikel
|
| 130 |
Pitavastatin: A Review in Hypercholesterolemia
|
Hoy, Sheridan M.
|
|
2017
|
|
2 |
p. 157-168
|
artikel
|
| 131 |
Placebo Effect and Efficacy of Nebivolol in Patients with Hypertension not Controlled with Lisinopril or Losartan: A Phase IV, Randomized, Placebo-Controlled Trial
|
Weiss, Robert J.
|
|
2013
|
|
2 |
p. 129-140
|
artikel
|
| 132 |
Plasma Metabolites as Predictors of Warfarin Outcome in Atrial Fibrillation
|
Bawadikji, Abdulkader Ahmad
|
|
|
|
2 |
p. 169-177
|
artikel
|
| 133 |
Potential Mechanisms of Benefit with Thalidomide in Chronic Heart Failure
|
Aukrust, Pål
|
|
2007
|
|
2 |
p. 127-134
|
artikel
|
| 134 |
Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise
|
Braschi, Annabella
|
|
2019
|
|
2 |
p. 133-171
|
artikel
|
| 135 |
Prasugrel versus Clopidogrel Antiplatelet Therapy after Acute Coronary Syndrome
|
Tcheng, James E.
|
|
2012
|
|
2 |
p. 83-91
|
artikel
|
| 136 |
Predicting the Impact of Polypill Use in a Metabolic Syndrome Population: An Effectiveness and Cost-Effectiveness Analysis
|
Zomer, Ella
|
|
2013
|
|
2 |
p. 121-128
|
artikel
|
| 137 |
Predictors of Annual Pharmaceutical Costs in Australia for Community-Based Individuals with, or at Risk of, Cardiovascular Disease
|
Ademi, Zanfina
|
|
2010
|
|
2 |
p. 85-94
|
artikel
|
| 138 |
Predictors of Left Ventricular Dysfunction in Friedreich’s Ataxia in a 16-Year Observational Study
|
Legrand, Lise
|
|
|
|
2 |
p. 209-216
|
artikel
|
| 139 |
Predictors of Poor Very Early Diuretic Response and Effectiveness of Early Tolvaptan in Symptomatic Acute Heart Failure
|
Takimura, Hideyuki
|
|
|
|
2 |
p. 185-196
|
artikel
|
| 140 |
Preservation of Bioavailability of Ingredients and Lack of Drug-Drug Interactions in a Novel Five-Ingredient Polypill (Polycap™)
|
Patel, Anil
|
|
2010
|
|
2 |
p. 95-103
|
artikel
|
| 141 |
Prior Antiplatelet Use and Cardiovascular Outcomes in Patients Presenting with Acute Coronary Syndromes
|
El-Menyar, Ayman
|
|
2012
|
|
2 |
p. 127-135
|
artikel
|
| 142 |
Prolonged Clopidogrel Use is Associated with Improved Clinical Outcomes Following Drug-Eluting But Not Bare Metal Stent Implantation
|
Cruden, Nicholas L.
|
|
2016
|
|
2 |
p. 111-118
|
artikel
|
| 143 |
Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States
|
Bhambri, Rahul
|
|
|
|
2 |
p. 197-206
|
artikel
|
| 144 |
Real World Outcomes Associated with Idarucizumab: Population-Based Retrospective Cohort Study
|
Singh, Sonal
|
|
|
|
2 |
p. 161-168
|
artikel
|
| 145 |
Review of Challenges in Optimizing Oral Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
|
Fernandez, Maria M.
|
|
2013
|
|
2 |
p. 87-102
|
artikel
|
| 146 |
Rosuvastatin
|
Keating, Gillian M.
|
|
2008
|
|
2 |
p. 127-146
|
artikel
|
| 147 |
SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis
|
Poonchuay, Natnicha
|
|
|
|
2 |
p. 211-240
|
artikel
|
| 148 |
Secondary Prevention of Coronary Artery Disease with Antimicrobials
|
Muhlestein, Joseph B.
|
|
2002
|
|
2 |
p. 107-118
|
artikel
|
| 149 |
Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease
|
Nicholls, Stephen J.
|
|
2017
|
|
2 |
p. 109-115
|
artikel
|
| 150 |
Serum Cystatin C as a Risk Factor for Supratherapeutic Digoxin Concentration in Elderly Patients with Heart Failure and Chronic Kidney Disease
|
Lu, Jie-Jiu
|
|
|
|
2 |
p. 303-311
|
artikel
|
| 151 |
Short-Term Effects of Tolvaptan in Tricuspid Insufficiency Combined with Left Heart Valve Replacement-Caused Volume-Overload Patients: Results of a Prospective Pilot Study
|
Yuan, Fang
|
|
2018
|
|
2 |
p. 211-218
|
artikel
|
| 152 |
Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
|
Navarese, Eliano Pio
|
|
2013
|
|
2 |
p. 79-87
|
artikel
|
| 153 |
Sulodexide in the Treatment of Chronic Venous Disease
|
Andreozzi, Giuseppe Maria
|
|
2012
|
|
2 |
p. 73-81
|
artikel
|
| 154 |
Tackling Residual Atherosclerotic Risk in Statin-Treated Adults: Focus on Emerging Drugs
|
Takata, Kohei
|
|
2018
|
|
2 |
p. 113-131
|
artikel
|
| 155 |
Temporary Adjunctive Cilostazol vs Clopidogrel Loading for ST-segment Elevation Acute Myocardial Infarction
|
Tanaka, Akihito
|
|
2014
|
|
2 |
p. 131-136
|
artikel
|
| 156 |
The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis
|
Kow, Chia Siang
|
|
|
|
2 |
p. 167-181
|
artikel
|
| 157 |
The AWAKE-HF Study: Sacubitril/Valsartan Impact on Daily Physical Activity and Sleep in Heart Failure
|
Khandwalla, Raj M.
|
|
|
|
2 |
p. 241-254
|
artikel
|
| 158 |
The Current Role of Clevidipine in the Management of Hypertension
|
Xu, Bo
|
|
|
|
2 |
p. 127-139
|
artikel
|
| 159 |
The Effect of Endothelin Receptor Antagonists in Patients with Eisenmenger Syndrome: A Systematic Review
|
Elshafay, Abdelrahman
|
|
2017
|
|
2 |
p. 93-102
|
artikel
|
| 160 |
The Effect of Statins on the No-Reflow Phenomenon
|
Zhao, Jing-Lin
|
|
2009
|
|
2 |
p. 81-89
|
artikel
|
| 161 |
The Next Generation of Drug-Eluting Stents
|
Ramcharitar, Steve
|
|
2007
|
|
2 |
p. 81-93
|
artikel
|
| 162 |
Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence
|
Mooradian, Arshag D.
|
|
2016
|
|
2 |
p. 83-95
|
artikel
|
| 163 |
Therapy of Hypertension in African Americans
|
Flack, John M.
|
|
2011
|
|
2 |
p. 83-92
|
artikel
|
| 164 |
The Rationale for and Clinical Pharmacology of Prasugrel 5 mg
|
Jakubowski, Joseph A.
|
|
2016
|
|
2 |
p. 109-121
|
artikel
|
| 165 |
The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review
|
Molina de Salazar, Dora Inés
|
|
|
|
2 |
p. 197-209
|
artikel
|
| 166 |
The sGC-cGMP Signaling Pathway as a Potential Therapeutic Target in Doxorubicin-Induced Heart Failure: A Narrative Review
|
Cho, Haneul
|
|
|
|
2 |
p. 117-125
|
artikel
|
| 167 |
The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach
|
Fras, Zlatko
|
|
|
|
2 |
p. 139-151
|
artikel
|
| 168 |
Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus
|
Hernandez, Adrian V.
|
|
2011
|
|
2 |
p. 115-128
|
artikel
|
| 169 |
Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI
|
Ayoub, Ali
|
|
|
|
2 |
p. 153-163
|
artikel
|
| 170 |
Transcatheter Aortic Valve Replacement: Focus on Sex-Related Differences in Outcomes
|
Flaherty, Michael P.
|
|
2015
|
|
2 |
p. 95-101
|
artikel
|
| 171 |
Trimetazidine Administration Minimizes Myocardial Damage and Improves Left Ventricular Function after Percutaneous Coronary Intervention
|
Labrou, Alexandra
|
|
|
|
2 |
p. 143-150
|
artikel
|
| 172 |
Trimetazidine Administration Minimizes Myocardial Damage and Improves Left Ventricular Function after Percutaneous Coronary Intervention
|
Labrou, Alexandra
|
|
2007
|
|
2 |
p. 143-150
|
artikel
|
| 173 |
Varespladib
|
|
|
2011
|
|
2 |
p. 137-143
|
artikel
|
| 174 |
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes
|
Böttcher, Michael
|
|
|
|
2 |
p. 145-155
|
artikel
|
| 175 |
Which Strategy Is More Effective for the Treatment of Cardiovascular Disease
|
Miura, Shin-ichiro
|
|
2008
|
|
2 |
p. 88-90
|
artikel
|
Tijdschrift beschrijving